Clicbiotech
1 known investors
ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.
BiotechDeep TechHealthtech
Founders & leadership
JD
John DobakCEO and Co-Founder
JH
Jay HaganBoard Member and Co-Founder
BS
Bruce SteelBoard Member and Co-Founder
OO
Olivia OsbornCo-Founder/Advisor